Infinity Pharma to stop rheumatoid arthritis treatment

(Reuters) - Infinity Pharmaceuticals Inc said it would stop testing its lead drug as a treatment for rheumatoid arthritis after it failed a study, the second failure for the drug in four months.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news